Topic: Amgen Inc.
Merger Monday" has a new a rival.. . The first day of the work week has typically been a hot day for mergers, acquisitions, and licensing deals...
BMO Capital Markets upped their price target on shares of Amgen (NASDAQ: AMGN) to $64.00 in a research note issued on Friday. They currently have a...
Amgen (NASDAQ: AMGN)'s stock had its "neutral" rating reiterated by Goldman Sachs (NYSE: GS) in a research note issued on Friday.. . Separately...
Biotechnology, or biotech, is a type of applied biology that uses organisms and/or bioprocesses in engineering, technology, medicine and any other...
Jefferies Group (NYSE: JEF) increased their price target on shares of Amgen (NASDAQ: AMGN) to $78.00 in a research note issued on Friday.....
Amgen (NASDAQ: AMGN)'s stock had its "buy" rating reiterated by investment analysts at Jefferies Group (NYSE: JEF) in a note issued to investors on...
January 27, 2012 09:05 AM Eastern Time . SAN DIEGO--(BUSINESS WIRE)--Shareholder rights firm Robbins Umeda LLP has commenced an investigation into...
Executives. . Arvind Sood - Vice President of Investor Relations. . Anthony C. Hooper - Executive Vice President of Global Commercial Operations. ...
Amgen Inc. said Thursday that its fourth-quarter profit fell 8.5 percent as its expenses for taxes and for producing and selling drugs rose faster ...
Amgen Inc. (AMGN), the company that agreed to buy Micromet Inc. (MITI) today for $1.16 billion, reported fourth- quarter profit that fell short of...